Back
ESC Premium Access

In a 36-week placebo-controlled phase 2 trial in patients with non-alcoholic steatohepatitis (NASH), treatment with mgl-3196 (resmetirom) significantly reduces atherogenic lipoprotein particles

Session: Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations
Topic: Drug therapy
Speaker: Doctor R. Taub (Conshohocken, US)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Rebecca Taub

Madrigal Pharmaceuticals, Conshohocken (United States of America)
0 follower

29 more presentations in this session

The selected stress testing protocol is independently associated with mortality irrespective of exercise capacity and comorbidities.

Speaker: Doctor S. Harb (Cleveland, US)

Access
Abstract
Slides
Thumbnail

Exercise-induced cardiac troponin I release and incident cardiovascular morbidity and mortality

Speaker: Doctor V. Aengevaeren (Nijmegen, NL)

Access
Abstract
Slides
Thumbnail

Evaluation of endothelial progenitor cells as cardiovascular prognostic biomarkers in hemodialysis patients

Speaker: Doctor T. Infante (Naples, IT)

Access
Abstract
Slides
Thumbnail

Female sex is an independent predictor of mortality in patients with STEMI in Spain: a study in 325,017 episodes over 11 years (2005-2015)

Speaker: Doctor M. Anguita Sanchez (Cordoba, ES)

Access
Abstract
Slides
Thumbnail

Novel cardiotropic AAV variant C102 vectors show superior gene delivery & reduced immunogenicity in non-human primates, transduction of human cardiomyocytes, & correction of Fabry disease phenotype

Speaker: Doctor G. Brooks (London, GB)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 2 - Risk Factors and Prevention, Cardiovascular Disease in Special Populations

Speakers: Doctor R. Taub, Doctor S. Harb, Doctor V. Aengevaeren, Doctor T. Infante, Doctor M. Anguita Sanchez...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources